[1
]
From the Los Angeles Biomedical Research Institute (L.G.M., S.J.E.) and Division of
Infectious Diseases, Harbor-UCLA (University of California, Los Angeles) Medical Center
(L.G.M., S.J.E.), Torrance, David Geffen School of Medicine at UCLA, Los Angeles (L.G.M.,
S.J.E.), Division of Plastic and Reconstructive Surgery, University of California,
San Francisco (UCSF) (D.Y.), and Division of Infectious Diseases, San Francisco General
Hospital and UCSF (M.D.D., H.F.C.), San Francisco - all in California; Division of
Pediatric Infectious Diseases, University of Chicago, Chicago (R.S.D.); Division of
Pediatric Infectious Diseases, Vanderbilt University, Nashville (C.B.C.); the EMMES
Corporation, Rockville, MD (S.P.); and Cota Enterprises, Meriden, KS (R.J.H.).